IL17A and atherosclerosis: Moreover, TNF-α, IL-17, and IL-23 inhibitors have been associated with favorable effects on endothelial function and reduced oxidative stress, key mechanisms in the prevention of cardiovascular conditions such as atherosclerosis, peripheral artery disease, and cerebrovascular events.